battling cancer

Porton Advanced and EVA Pharma collaborate for CAR T-cell therapies
Porton Advanced Solutions and EVA Pharma have signed a memorandum of understanding (MoU) to enhance the development and manufacturing capabilities for chimeric antigen receptor (CAR) T-cell therapies at the...